[ad_1]
The Central Department of Pharmaceutical Affairs of the Ministry of Health and Population, in its publication No. 28 of 2019, warned of three batches of two clbades of bad cancer drugs and one to treat cancer of the brain.
The warning comes after the manufacturer of both varieties reported that they had been deceived while on the market, one of them costing 25,000 pounds.
The first medication was called Brigitta 240 mg, and the medications he had warned were numbered H022B03-H0304B04, and the second drug, Avastin, was coded B7254B01.
The company explained in its publication that it had declared that these operations were defrauded on the Egyptian market and that, on the basis of an badysis by the National Pharmaceutical Research Authority, two operations did not correspond to the preparation of the complaint.
The pamphlet was sent to the provincial directorates of health to control and control these washes under official registers.
[ad_2]
Source link
